Advisor Group Holdings, Inc. Arbutus Biopharma Corp Transaction History

Advisor Group Holdings, Inc.

$42.1 Billion
Q1 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 1,344,906 shares of ABUS stock, worth $4.52 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,344,906

Previous 1,362,424 1.29%

Holding current value

$4.52 Million

Previous $4.46 Million 5.34%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$3.06 - $3.59 $53,605 - $62,889	-17,518 Reduced 1.29%	1,344,906 $4.69 Million
Q4 2024 Feb 07, 2025	SELL	$3.18 - $4.2 $31,577 - $41,706	-9,930 Reduced 0.72%	1,362,424 $4.46 Million
Q3 2024 Nov 13, 2024	BUY	$3.12 - $4.56 $7,846 - $11,468	2,515 Added 0.18%	1,372,354 $5.28 Million
Q2 2024 Aug 13, 2024	BUY	$2.52 - $3.63 $5,796 - $8,349	2,300 Added 0.17%	1,369,839 $4.23 Million
Q4 2023 Feb 12, 2024	SELL	$1.69 - $2.54 $845 - $1,270	-500 Reduced 0.04%	1,367,539 $3.42 Million
Q3 2023 Nov 13, 2023	BUY	$1.9 - $2.27 $1,900 - $2,270	1,000 Added 0.07%	1,368,039 $2.78 Million
Q2 2023 Aug 10, 2023	SELL	$2.24 - $3.06 $21,244 - $29,021	-9,484 Reduced 0.69%	1,367,039 $3.14 Million
Q4 2022 Feb 10, 2023	BUY	$1.91 - $2.85 $22,920 - $34,200	12,000 Added 0.88%	1,376,523 $3.21 Million
Q2 2022 Aug 10, 2022	SELL	$1.98 - $3.17 $1 - $3	-1 Reduced -0.0%	1,364,523 $3.7 Million
Q1 2022 May 04, 2022	SELL	$2.42 - $3.98 $96 - $159	-40 Reduced -0.0%	1,364,524 $4.07 Million
Q3 2021 Nov 05, 2021	SELL	$2.65 - $4.62 $13,581 - $23,677	-5,125 Reduced 0.37%	1,364,564 $5.85 Million
Q2 2021 Aug 02, 2021	SELL	$2.5 - $3.51 $1,000 - $1,404	-400 Reduced 0.03%	1,369,689 $4.15 Million
Q1 2021 May 13, 2021	SELL	$3.14 - $4.84 $3,140 - $4,840	-1,000 Reduced 0.07%	1,370,089 $4.56 Million
Q4 2020 Feb 10, 2021	BUY	$2.76 - $4.97 $29,807 - $53,676	10,800 Added 0.79%	1,371,089 $4.87 Million
Q3 2020 Nov 12, 2020	SELL	$1.75 - $6.2 $725,630 - $2.57 Million	-414,646 Reduced 23.36%	1,360,289 $4.26 Million
Q2 2020 Aug 14, 2020	BUY	$0.91 - $2.36 $18 - $47	20 Added 0.0%	1,774,935 $3.23 Million
Q1 2020 May 18, 2020	BUY	$1.01 - $3.42 $1.79 Million - $6.07 Million	1,774,915 New	1,774,915 $1.79 Million

Others Institutions Holding ABUS

# of Institutions

191

Shares Held

111M

Call Options Held

866K

Put Options Held

608K

View Full List

About Arbutus Biopharma Corp

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $504M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

More about ABUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Arbutus Biopharma Corp Transaction History